Skip to content
Neuropediatoolkit

Neuropediatoolkit

  • Toolkit
  • Guía clínica
  • Criterios de remisión
  • Escuela
  • Lab
  • Archive
  • À propos

PTEN.

Posted byAlberto Alcantud 11 de September de 202222 de June de 2026

Fondation PHTS.

Posted byAlberto Alcantud11 de September de 202222 de June de 2026Posted inRisque oncologique

Post navigation

Previous Post Previous post:
Neurofibromatose type 1.
Next Post Next post:
Troubles neurogénétiques et risque oncologique.
Neuropediatoolkit, Proudly powered by WordPress.
French
Spanish English German Russian Chinese Japanese